Source: http://www.google.com/patents/US8012077?dq=%22edwin+asa+markham%22
Timestamp: 2013-12-05 08:09:49
Document Index: 18767114

Matched Legal Cases: ['Application No. 2007554191', 'Application No. 2007554191', 'Application No. 2007', 'Application No. 2007', 'Application No. 2007554191', 'Application No. 2007554191', 'Application No. 2007', 'Application No. 2007']

Patent US8012077 - Blood separating device - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Advanced Patent Search | Sign inAdvanced Patent SearchPatentsA device for separating components of a composition according to density. The device includes a rotatable chamber and a plurality of buoys. The rotatable chamber has an axis of rotation. The plurality of buoys are positioned within the rotatable chamber and about the axis of rotation. The buoys are radially...http://www.google.com/patents/US8012077?utm_source=gb-gplus-sharePatent US8012077 - Blood separating devicePublication numberUS8012077 B2Publication typeGrantApplication numberUS 12/126,028Publication dateSep 6, 2011Filing dateMay 23, 2008Priority dateMay 23, 2008Also published asUS8142342, US20090289014, US20110319249Publication number12126028, 126028, US 8012077 B2, US 8012077B2, US-B2-8012077, US8012077 B2, US8012077B2InventorsJacy C. HoeppnerOriginal AssigneeBiomet Biologics, LlcPatent Citations (100), Non-Patent Citations (90), Classifications (12), Legal Events (3) External Links: USPTO, USPTO Assignment, EspacenetBlood separating deviceUS 8012077 B2Abstract A device for separating components of a composition according to density. The device includes a rotatable chamber and a plurality of buoys. The rotatable chamber has an axis of rotation. The plurality of buoys are positioned within the rotatable chamber and about the axis of rotation. The buoys are radially movable between an expanded position in which the buoys are at a first location relative to the axis of rotation and a contracted position in which the buoys are at a second location relative to the axis of rotation. The first location is further from the axis of rotation than the second location is. The buoys are movable in response to force generated during rotation of the rotatable chamber.
FIELD The present disclosure relates to devices and methods for separating blood into its different fractions or parts.
SUMMARY The present teachings provide for a device for separating components of a composition according to density. The device includes a rotatable chamber and a plurality of buoys. The rotatable chamber has an axis of rotation. The plurality of buoys are positioned within the rotatable chamber and about the axis of rotation. The buoys are radially movable between an expanded position in which the buoys are at a first location relative to the axis of rotation and a contracted position in which the buoys are at a second location relative to the axis of rotation. The first location is further from the axis of rotation than the second location is. The buoys are movable in response to force generated during rotation of the rotatable chamber.
With initial reference to FIGS. 1, 2A, and 2B, a device for separating components of a multi-component composition according to the present teachings is illustrated at reference numeral 10. The device 10 generally includes a housing 12, a cover 14, and a plurality of buoys 16. The device 10 can be rotated or spun using a suitable rotating device 17, such as a Vortech� Base manufactured by Biomet, Inc. of Warsaw, Ind. (model nos. 800-7500A and 800-7600A, for example). The rotating device 17 can include any suitable mechanism for transferring torque from the rotating device 17 to the blood separation device 10, such as a rotating rod or spindle 19. The device 10 can be used to separate components of a variety of different compositions, such as whole blood, blood plasma, mononuclear cells (�MNC�), bone marrow aspirate, spinal fluid, and fat, for example.
With reference to FIGS. 4, 5A, and 5B, a blood separation device 100 is illustrated. Features of the blood separation device 100 that are similar to the features of the blood separation device 10 are illustrated with like reference numbers, but also including the letter �A.� With respect to these similar features, the above description of the device 10 also applies to the device 100.
With reference to FIGS. 6, 7A, 7B, 8A, and 8B a blood separation device 200 is illustrated. Features of the blood separation device 200 that are similar to the features of the blood separation device 10 are illustrated with like reference numbers, but also including the letter �B�. With respect to these similar features, the above description of the device 10 also applies to the device 200.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS2553004Mar 11, 1949May 15, 1951Rabatine MichaelDividing protractorUS3141846Apr 5, 1962Jul 21, 1964Western States Machine CoLoad control unit for cyclical centrifugal installationUS3409165Apr 3, 1967Nov 5, 1968Olin MathiesonFloating deckUS3420374Apr 11, 1967Jan 7, 1969Ajinomoto KkMethod and device for controlling feed in a centrifugal separatorUS3441143Feb 10, 1967Apr 29, 1969Marvel Eng CoPlural element filter assemblyUS3453364Aug 12, 1964Jul 1, 1969Pharmacia AbTherapeutic infusion and injection composition containing hydroxyalkyl dextranUS3469369Dec 29, 1966Sep 30, 1969Bell Telephone Labor IncMethod for preparing and applying a viscous fluidUS3508653Nov 17, 1967Apr 28, 1970Charles M ColemanMethod and apparatus for fluid handling and separationUS3593915Apr 30, 1969Jul 20, 1971Westphalia Separator AgControlled desludging of centrifugal separatorsUS3647070Jun 11, 1970Mar 7, 1972Technicon CorpMethod and apparatus for the provision of fluid interface barriersUS3779383Apr 25, 1972Dec 18, 1973Becton Dickinson CoSealed assembly for separation of blood components and methodUS3785549Jul 31, 1972Jan 15, 1974Haemonetics CorpCentrifuge chuck for disposable, snap-in centrifuge rotorUS3814248Feb 23, 1972Jun 4, 1974Corning Glass WorksMethod and apparatus for fluid collection and/or partitioningUS3850369Mar 8, 1973Nov 26, 1974Coulter ElectronicsCentrifuge for preparing platelet rich plasmaUS3879295Aug 17, 1973Apr 22, 1975Eastman Kodak CoVacutainer with positive separation barrierUS3894952Feb 27, 1974Jul 15, 1975Becton Dickinson CoSerum/plasma separator assembly having interface-seeking pistonUS3897343Feb 27, 1974Jul 29, 1975Becton Dickinson CoPlasma separator-hydrostatic pressure typeUS3909419Feb 27, 1974Sep 30, 1975Becton Dickinson CoPlasma separator with squeezed sealantUS3929646Jul 22, 1974Dec 30, 1975Technicon InstrSerum separator and fibrin filterUS3931010Feb 27, 1974Jan 6, 1976Becton, Dickinson And CompanySerum/plasma separators with centrifugal valvesUS3931018Aug 9, 1974Jan 6, 1976Becton, Dickinson And CompanyAssembly for collection, separation and filtration of bloodUS3935113Feb 27, 1974Jan 27, 1976Becton, Dickinson And CompanySerum/plasma separator with centrifugal valveUS3941699Feb 27, 1974Mar 2, 1976Becton, Dickinson And CompanyPlasma separator with centrifugal valveUS3972812May 8, 1975Aug 3, 1976Becton, Dickinson And CompanyBlood serum separation filter discUS3982691Oct 9, 1974Sep 28, 1976Schlutz Charles ACentrifuge separation and washing device and methodUS4001122Aug 22, 1973Jan 4, 1977Telan CorporationMethod and device for separating blood componentsUS4046699Nov 1, 1976Sep 6, 1977Corning Glass WorksAccess device for centrifugal separation assembliesUS4055501Jan 16, 1976Oct 25, 1977Sherwood Medical Industries Inc.Fluid collection device with phase partitioning meansUS4059108Jul 15, 1975Nov 22, 1977Haemonetics CorporationProcess for pheresis procedure and disposable pheresis bowl thereforUS4077396Dec 2, 1976Mar 7, 1978Wardlaw Stephen CMaterial layer volume determinationUS4152270Jul 1, 1977May 1, 1979Sherwood Medical Industries Inc.Phase separation deviceUS4159896May 30, 1978Jul 3, 1979James V. Massey, IIIEnhancement of separation of cell layers in centrifuged blood sampleUS4187979Sep 21, 1978Feb 12, 1980Baxter Travenol Laboratories, Inc.Method and system for fractionating a quantity of blood into the components thereofUS4204537Jun 27, 1977May 27, 1980Haemonetics CorporationProcess for pheresis procedure and disposable plasmaUS4225580Oct 2, 1975Sep 30, 1980Pharmacia AktiebolagMethod for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the methodUS4229298Feb 5, 1979Oct 21, 1980The Western States Machine CompanyMethod and apparatus for determining the thickness of a charge wall formed in a centrifugal basketUS4269718May 5, 1980May 26, 1981The Institutes Of Medical SciencesProcess and device for centrifugal separation of plateletsUS4294707Mar 19, 1980Oct 13, 1981Terumo CorporationMethod for separating blood and a barrier device thereforUS4298598Feb 4, 1980Nov 3, 1981Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteTissue adhesiveUS4300717Oct 27, 1980Nov 17, 1981Haemonetics CorporationRotary centrifuge sealUS4303193Jan 22, 1979Dec 1, 1981Haemonetics CorporationApparatus for separating blood into components thereofUS4314823Sep 13, 1979Feb 9, 1982Dionex CorporationCombination apparatus and method for chromatographic separation and quantitative analysis of multiple ionic speciesUS4322298Jun 1, 1981Mar 30, 1982Advanced Blood Component Technology, Inc.Centrifugal cell separator, and method of use thereofUS4332351Sep 22, 1980Jun 1, 1982International Business Machines CorporationBlood fraction extracting centrifugeUS4362567Feb 4, 1980Dec 7, 1982Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteTissue adhesiveUS4364832Jan 18, 1982Dec 21, 1982Ballies Uwe WSeparating member in a separating tube for centrifugal separationUS4377572Jul 7, 1981Mar 22, 1983Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteTissue adhesiveUS4414976Sep 13, 1982Nov 15, 1983Immuno Aktiengesellschaft Fur Chemischmedizinische ProdukteTissue adhesiveUS4416654Sep 3, 1981Nov 22, 1983Haemonetics CorporationPheresis apparatusUS4417981May 4, 1981Nov 29, 1983Becton, Dickinson And CompanyBlood phase separator deviceUS4424132Jan 29, 1982Jan 3, 1984Asahi Kasei Kogyo Kabushiki KaishaApparatus and method for separating blood componentsUS4427650Jun 7, 1982Jan 24, 1984Serapharm Michael StroetmannEnriched plasma derivative for advancement of wound closure and healingUS4427651Jun 7, 1982Jan 24, 1984Serapharm Michael StroetmannEnriched plasma derivative for enhancement of wound closure and coverageUS4442655Jun 25, 1982Apr 17, 1984Serapharm Michael StroetmannFibrinogen-containing dry preparation, manufacture and use thereofUS4446021Aug 4, 1982May 1, 1984Krauss-Maffei AktiengesellschaftFilter-medium support plate for centrifugal filterUS4453939Feb 11, 1982Jun 12, 1984Hormon-Chemie Munchen GmbhComposition for sealing and healing woundsUS4464167Aug 1, 1983Aug 7, 1984Haemonetics CorporationPheresis apparatusUS4537767Sep 24, 1982Aug 27, 1985Pharmacia AktiebolagMethod for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the methodUS4610656Aug 21, 1984Sep 9, 1986Mehealus PartnershipFully portable semi-automatic mechanical heart-lung substitution system and methodUS4617009Nov 28, 1983Oct 14, 1986Seroteknik HgMethod and apparatus for centrifugal batch separation of bloodUS4627879Jan 3, 1985Dec 9, 1986The Trustees Of Columbia University In The City Of New YorkFibrin adhesive prepared as a concentrate from single donor fresh frozen plasmaUS4631055Feb 26, 1985Dec 23, 1986Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteApparatus for applying a tissue adhesiveUS4632761Aug 15, 1983Dec 30, 1986W. R. Grace & Co.Centrifugal microconcentrator and methods for its useUS4639316Dec 14, 1984Jan 27, 1987Becton, Dickinson And CompanyAutomatic liquid component separatorUS4650678Aug 10, 1984Mar 17, 1987Behringwerke AktiengesellschaftReadily dissolvable lyophilized fibrinogen formulationUS4655211Aug 8, 1985Apr 7, 1987Unitika Ltd.Hemostatic agentUS4672969Oct 6, 1983Jun 16, 1987Sonomo CorporationLaser healing methodUS4675117Mar 20, 1985Jun 23, 1987Fresenius AgMethod of separating blood and apparatus for carrying out the methodUS4680025Nov 27, 1984Jul 14, 1987Baxter Travenol Laboratories, Inc.Blood component collection systems and methodsUS4714457Sep 15, 1986Dec 22, 1987Robert AlterbaumMethod and apparatus for use in preparation of fibrinogen from a patient's bloodUS4722790Apr 29, 1985Feb 2, 1988Cawley Leo POn-line plasma modification meansUS4724317Dec 5, 1985Feb 9, 1988Baxter Travenol Laboratories, Inc.Optical data collection apparatus and method used with moving membersUS4735616Jun 17, 1986Apr 5, 1988Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteArrangement for applying a tissue adhesiveUS4735726Jan 28, 1987Apr 5, 1988E. I. Du Pont De Nemours And CompanyPlasmapheresis by reciprocatory pulsatile filtrationUS4738655Jun 17, 1987Apr 19, 1988Utah Bioresearch, Inc.Apparatus and method for obtaining a rapid hematocritUS4755300Dec 23, 1985Jul 5, 1988Haemonetics CorporationCouette membrane filtration apparatus for separating suspended components in a fluid medium using high shearUS4755301Aug 12, 1986Jul 5, 1988W. R. Grace & Co.Apparatus and method for centrifugal recovery of retentateUS4770779Jul 1, 1987Sep 13, 1988Terumo CorporationApparatus for separating bloodUS4776964Aug 24, 1984Oct 11, 1988William F. McLaughlinClosed hemapheresis system and methodUS4818291Dec 10, 1987Apr 4, 1989Ajinomoto Co., Inc.Silk-fibroin and human-fibrinogen adhesive compositionUS4818386Oct 8, 1987Apr 4, 1989Becton, Dickinson And CompanyDevice for separating the components of a liquid sample having higher and lower specific gravitiesUS4828710Jul 21, 1987May 9, 1989Mitsui Toatsu Chemicals, IncorporatedMethod for the extraction of water from macromolecular solutionsUS4832851Feb 2, 1987May 23, 1989W. R. Grace & Co.Centrifugal force-enhanced filtration of fluidsUS4834890Jan 30, 1987May 30, 1989Baxter International Inc.Centrifugation pheresis systemUS4839058Oct 1, 1987Jun 13, 1989Cawley Leo POn-line plasma modification methodUS4844818Oct 23, 1987Jul 4, 1989Becton Dickinson & CompanyMethod for separating the cellular components of blood samplesUS4846780Aug 10, 1988Jul 11, 1989Exxon Production Research CompanyCentrifuge processor and liquid level control systemUS4846974Nov 14, 1985Jul 11, 1989Norfolk Scientific, Inc.Centrifuge system and fluid container thereforUS4853137Aug 27, 1986Aug 1, 1989Ersson Nils OlofMethod and device for separating serum/plasma from bloodUS4871462Jun 5, 1987Oct 3, 1989Haemonetics CorporationEnhanced separation of blood componentsUS4874368Jul 25, 1988Oct 17, 1989Micromedics, Inc.Fibrin glue delivery systemUS4877520Jun 6, 1988Oct 31, 1989Becton, Dickinson And CompanyDevice for separating the components of a liquid sample having higher and lower specific gravitiesUS4879031Apr 6, 1988Nov 7, 1989Dideco S.P.A.Blood centrifugation cellUS4900453Aug 5, 1988Feb 13, 1990Krause-Maffei AktiengesellschaftFilter centrifuge controlUS4902281Aug 16, 1988Feb 20, 1990Corus Medical CorporationFibrinogen dispensing kitUS4928603Jun 6, 1988May 29, 1990The Trustees Of Columbia University In The City Of New YorkMethod of preparing a cryoprecipitated suspension and use thereofUS4929242May 8, 1989May 29, 1990Baxter International Inc.Solution and method for maintaining patency of a catheterUS4933291Sep 14, 1987Jun 12, 1990Eastman Kodak CompanyCentrifugable pipette tip and pipette thereforUS20040251217 *May 23, 2003Dec 16, 2004Michael LeachApparatus and method for separating and concentrating fluids containing multiple componentsUSRE32089Feb 17, 1981Mar 4, 1986Amicon CorporationBlood fractionating process and apparatus for carrying out same* Cited by examinerNon-Patent CitationsReference1"Cell Isolation Techniques, Methods and Materials, Working with Enzymes," (2004) (9 pages) Worthington Biochemical Corp.2"Cell Isolation Theory, Tissue Types," (2004) (5 pages) Worthington Biochemical Corp.3"Cytori Celution Cell Concentrate Device," Exhibit 14, 510(k) Summary, FDA approval K060482 (Sep. 28, 2006).4"Frequently Asked Questions, 1. Kits, 2. Engzymes," (2003) 3 pages Worthington Biochemical Corp.5"Sefar Solutions for the Healthcare Industry," brochure (2003) 9 pages Sefar Medifab�.6"Trypsinization of Adherent Cells," (undated) 2 pages.7Anesthesiology, vol. 81, No. 4, pp. 1074-1077, Oct. 1994, Hiromasa Mitsuhata, M.D., et al., "An Anaphylactic Reaction to Topical Fibrin Glue".8Ann Thorac Surg, vol. 53, pp. 530-531, 1992, Mehmet C. Oz, M.D., et al., "Autologous Fibrin Glue From Intraoperatively Collected Platelet-Rich Plasma".9Ann Thorac Surg, vol. 56, pp. 387-389, 1993, Robert L. Quigley, M.D., et al., "Intraoperative Procurement of Autologous Fibrin Glue".10Berguer, R., R. L. Staerkel, E. E. Moore, F. A. Moore, W. B. Galloway, and M. B. Mockus. "Warning: fatal reaction to the use of fibrin glue in deep hepatic wounds. Case reports." J Trauma 31 (3 1991): 408-11.11Berruyer, M., J. Amiral, P. Ffrench, J. Belleville, O. Bastien, J. Clerc, A. Kassir, S. Estanove, and M. Dechavanne. "Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors," J Thorac Cardiovasc Surg 105 (5 1993): 892-7.12Biopolymers, vol. 27, pp. 763-774, 1988, Gerald Marx, "Mechanism of Fibrin Coagulation Based on Selective, Cation-Driven, Protofibral Association".13Casali, B., F. Rodeghiero, A. Tosetto, B. Palmieri, R. Immovilli, C. Ghedini, and P. Rivasi. "Fibrin glue from single-donation autologous plasmapheresis." Transfusion 32 (Jul. 1992): 641-3.14Collier, B.S. et al., "The pH Dependence of Quantitative Ristocetin-induced Platelet Aggregation: Theoretical and Practical Implications-A New Device for Maintenance of Platelet-Rich Plasma pH", Hematology Service, Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Md. 20014, Blood, vol. 47, No. 5 (May), 1976.15Collier, B.S. et al., "The pH Dependence of Quantitative Ristocetin-induced Platelet Aggregation: Theoretical and Practical Implications�A New Device for Maintenance of Platelet-Rich Plasma pH", Hematology Service, Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Md. 20014, Blood, vol. 47, No. 5 (May), 1976.16DelRossi, A. J., A. C. Cernaianu, R. A.Vertrees, C. J. Wacker, S. J. Fuller, J. Cilley Jr., and W. A. Baldino. "Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass." J Thorac Cardiovasc Surg 100 (2 1990): 281-6.17DeUgarte, M.D., Daniel A., et al., "Future of Fat as Raw Material for Tissue Regneration," (2007) pp. 215-219, Lippincott Williams & Wilkins, Inc.18DiMuzio, Paul et al., "Development of a Tissue-Engineered Bypass Graft Seeded with Stem Cells," Vasucular, vol. 14, No. 6, (2006) pp. 338-342, BC Decker, Inc.19Drug Intelligence and Clinical Pharmacy, vol. 22, pp. 946-952, Dec. 1988, Dennis F. Thompson, et al., "Fibrin Glue: A Review of Its Preparation, Efficacy, and Adverse Effects as a Topical Hemostat".20Edlich, Richard F., George T. Rodeheaver, and John G. Thacker. "Surgical Devices in Wound Healing Management." In Wound Healing: Biochemical & Clinical Aspects,ed. I. Kelman Cohen, Robert F. Diegelmann, and William J. Lindblad. 581-600. 1st ed., Vol. Philadelphia: W.B. Saunders Company, 1992).21Epstein, G. H., R. A. Weisman, S. Zwillenberg, and A. D. Schreiber. "A new autologous fibrinogen-based adhesive for otologic surgery." Ann Otol Rhinol Laryngol 95 (1 Pt 1 1986): 40-5.22First clinical results: Kuderma, H. and Helene Matras. "Die klinische Anwendung der Klebung van Nervenanastomosen mit Gerinnungssubstanzen bei der Rekonstruction verletzter peripherer Nerven." Wein Klin Wochenschr 87 (15 1975): 495-501.23Frasier, John K., et al., "Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes," Nature Clinical Practice Cardiovascular Medicine, vol. 3, Supplement 1 (Mar. 2006) pp. S33-S37.24Gibble, J. W. and P. M. Ness. "Fibrin glue: the perfect operative sealant?" Transfusion 30 (8 1990): 741-7.25Gimble, Jeffrey M., "Adipose-Derived Stem Cells for Regenerative Medicine," Circulation Research (2007) pp. 1249-1260, American Heart Association, Inc.26Gomillion, Cheryl T., et al., "Stem cells and adipose tissue engineering," Biomaterials 27, Science Direct (2006) pp. 6052-6063, Elsevier.27GPS� II System, Gravitational Platelet Separation System, "Accelerating the Body's Natural Healing Process," Cell Factor Technologies, Inc., Biomet Europe (2005) 16 pages, http://www.cellfactortech.com/global-products.cfm, printed Sep. 16, 2005.28GPS� II System, Gravitational Platelet Separation System, "User Manual," Cell Factor Technologies, Inc., Biomet Europe [date unknown] 13 pages, http://www.cellfactortech.com/global-products.cfm, printed Sep. 16, 2005.29GPS� II System, Gravitational Platelet Separation System, "Accelerating the Body's Natural Healing Process," Cell Factor Technologies, Inc., Biomet Europe (2005) 16 pages, http://www.cellfactortech.com/global�products.cfm, printed Sep. 16, 2005.30GPS� II System, Gravitational Platelet Separation System, "User Manual," Cell Factor Technologies, Inc., Biomet Europe [date unknown] 13 pages, http://www.cellfactortech.com/global�products.cfm, printed Sep. 16, 2005.31GPS� III System, GPS� III Platelet Separation System, Leadership through Technology, brochure, Jul. 2007 (8 sheets) .32GPS� System, "GPS� Platelet Concentrate System," Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (2004) (9 pages).33GPS� System, "Shoulder Recovery with the GPS� Platelet Concentrate System, Rotator Cuff Surgical Techniques," brochure, Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (2004) 6 pages.34GPS� System, "Shoulder Recovery with the GPS� Platelet Concentrate System, Rotator Cuff Surgical Techniques," Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (2004) 3 pages, http://www.cellfactortech.com/global-products.cfm, printed Sep. 16, 2005.35GPS� System, "Shoulder Recovery with the GPS� Platelet Concentrate System, Rotator Cuff Surgical Techniques," Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (2004) 3 pages, http://www.cellfactortech.com/global�products.cfm, printed Sep. 16, 2005.36Guilak, Frank, et al., "Adipose-derived adult stem cells for cartilage tissue engineering," Biorheology 41 (2004) pp. 389-399, IOS Press.37Harris, E.L.V. Concentration of the Extract. In. Protein Purification Methods: A Practical Approach Harris, E.L.V.; Angal, S.; Editors. (1989) Publisher: (IRL Press, Oxford, UK), pp. 67-69.38Hartman, A. R., D. K. Galanakis, M. P. Honig, F. C. Seifert, and C. E. Anagnostopoulos. "Autologous whole plasma fibrin gel. Intraoperative procurement." Arch Surg 127 (3 1992): 357-9.39Hattori, et al., "Osteogenic Potential of Human Adipose Tissue-Derived Stromal Cells as an Alternative Stem Cell Source," Cells Tissues Organs (2004) 178:2-12 Karger.40Hennis, H. L., W. C. Stewart, and E. K. Jeter. "Infectious disease risks of fibrin glue [letter]." Ophthalmic Surg 23 (9 1992): 640.41International Preliminary Examination Report and Written Opinion issued Aug. 31, 2010 for PCT/US2009/035564 claiming benefit of U.S. Appl. No. 61/078,178, filed Jul. 3, 2008 of which U.S. Appl. No. 12/395,085, filed Feb. 27, 2009 claims benefit.42International Preliminary Report on Patentability mailed Feb. 12, 2009, for PCT/US2007/017055 filed Jul. 31, 2007, which claims benefit of U.S. Appl. No. 60/834,550, filed Jul. 31, 2006, based on U.S. Appl. No. 60/723,312, filed Oct. 4, 2005; U.S. Appl. No. 60/654,718, filed Feb. 17, 2005; and U.S. Appl. No. 60/651,050, filed Feb. 7, 2005.43International Search Report and Written Opinion for PCT/US2006/003597 mailed Feb. 6, 2006.44International Search Report and Written Opinion for PCT/US2006/003599 mailed Aug. 21, 2006.45International Search Report and Written Opinion mailed Aug. 12, 2008 for PCT/US07/17055.46International Search Report and Written Opinion mailed Jul. 3, 2009 for PCT/US2009/035564 claiming benefit of U.S. Appl. No. 61/078,178, filed Jul. 3, 2008.47Jackson, C. M. and Y. Nemerson. "Blood coagulation." Annu Rev Biochem 49 (811 1980): 765-811.48Journal of Biomaterials Applications, vol. 7, pp. 309-353, Apr. 1993, David H. Sierra, "Fibrin Sealant Adhesive Systems: A review of their Chemistry, Material Properties and Clinical Appllications".49Journal of Oral Maxillofacial Surgery, vol. 43, pp. 605-611, 1985, Helene Matras, M.D., "Fibrin Seal: The State of the Art".50Kjaergard, H. K,, U. S. Weis-Fogh, H. Sorensen, J. Thiis, and I. Rygg. "A simple method of preparation o� autologous fibrin glue by means of ethanol." Surg Gynecol Obstet 175 (1 1992): 72-3.51Kjaergard, H. K., Fogh Us Weis, and J. J. Thiis. "Preparation of autologous fibrin glue from pericardial blood." Ann Thorac Sur 55 (2 1993): 543-4.52Laryngoscope vol. 99, pp. 974-976, Sep. 1989, Kyosti Laitakari, M.D., et al., "Autologous and Homologous Fibrinogen Sealants: Adhesive Strength".53Laryngoscope, vol. 95, pp. 1074-1076, Sep. 1985, Karl H. Siedentop, M.D., et al., "Autologous Fibrin Tissue Adhesive".54Laryngoscope, vol. 96, pp. 1062-1064, Oct. 1986, Karl H. Siedentop, M.D., et al., "Extended Experimental and Preliminary Surgical Findings with Autologous Fibrin Tissue Adhesive Made from Patient's Own Blood".55Lendeckel, Stefan, et al., "Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report," Journal of Cranio-Maxillofacial Surgery (2004) European Association for Cranio-Maxillofacial Surgery.56Lerner, R. and N. S. Binur. "Current status of surgical adhesives." J Surg Res 48 (2 1990): 165-81.57Marrowstim(TM) Concentration System, (2008) 20 pages Biomet Biologics, Inc.58Marrowstim� Concentration System, (2008) 20 pages Biomet Biologics, Inc.59Matras, Helene, H. P. Dinges, H. Lassmann, and B. Mamoli. "Zur nahtlosen interfaszikularen Nerventransplantation im Tierexperinnent." Wein Med Woschtr 122 (37 1972): 517-523.60Moretz, W., Jr., J Shea Jr., J. R. Emmett, and J Shea. "A simple autologous fibrinogen glue for otologic surgery." Otolaryngol Head Neck Surg 95 (1 1986): 122-4.61Nakagami, Hironori, et al., "Novel Autologous Cell Tehrapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue-Derived Stromal Cells," Angiogenesis by Adipose Tissue-Derived Cells, (2005) pp. 2542-2547, American Heart Association, Inc.62Nathan, Suresh et al., "Cell-Based Therapy in the Repair of Osteochondral Defects: A Novel Use for Adipose Tissue," Tissue Engineering, vol. 9, No. 4 (2003) pp. 733-744 Mary Ann Liebert, Inc.63Office Action mailed Apr. 6, 2010 for Japanese Application No. 2007554191 filed Aug. 7, 2007 has been provided including a partial translation thereof, which also cites JP2001017540. Japanese Application No. 2007554191 claims benefit of PCT/US2006/003597, filed Jan. 30, 2006; claiming priority from U.S. Appl. Nos. 60/651,050, filed Feb. 7, 2005; 60/654,718, filed Feb. 17, 2005; and 60/723,312, filed Oct. 4, 2005 of which U.S. Appl. No. 11/831,605 filed Jul. 31, 2007 and U.S. Appl. No. 12/772,497 filed May 3, 2010 claim benefit.64Office Action mailed Apr. 6, 2010 for Japanese Application No. 2007-554193 filed Aug. 23, 2007 has been provided including a partial translation thereof, which cites JP11-502502 and JP2001017540. Japanese Application No. 2007-554193 claims benefit of PCT/US2006/003599, filed Jan. 30, 2006; claiming priority from U.S. Appl. Nos. 60/651,050, filed Feb. 7, 2005; 60/654,718, filed Feb. 17, 2005; and 60/723,312, filed Oct. 4, 2005 of which U.S. Appl. No. 11/831,605 filed Jul. 31, 2007 and U.S. Appl. No. 12/772,497 filed May 3, 2010 claim benefit.65Office Action mailed Sep. 14, 2010 for Japanese Application No. 2007554191 filed Aug. 7, 2007 has been provided including a partial translation thereof. Japanese Application No. 2007554191 claims benefit of PCT/US2006/003597, filed Jan. 30, 2006; claiming priority from U.S. Appl. Nos. 60/651,050, filed Feb. 7, 2005; 60/654,718, filed Feb. 17, 2005; and 60/723,312, filed Oct. 4, 2005 of which U.S. Appl. No. 11/831,605 filed Jul. 31, 2007 and U.S. Appl. No. 12/772,497 filed May 3, 2010 claim benefit.66Office Action mailed Sep. 14, 2010 for Japanese Application No. 2007-554193 filed Aug. 23, 2007 has been provided including a partial translation thereof. Japanese Application No. 2007-554193 claims benefit of PCT/US2006/003599, filed Jan. 30, 2006; claiming priority from U.S. Appl. Nos. 60/651,050, filed Feb. 7, 2005; 60/654,718, filed Feb. 17, 2005; and 60/723,312, filed Oct. 04, 2005 of which U.S. Appl. No. 11/831,605 filed Jul. 31, 2007, and U.S. Appl. No. 12/772,497 filed May 3, 2010 claim benefit.67Otolaryngologic Clinics of North America, vol. 27, No. 1, pp. 203-209, Feb. 1994, Dean M. Toriumi, M.D., et al., "Surgical Tissue Adhesives in Otolaryngology-Head and Neck Surgery".68Parker, Anna M., et al., Adipose-derived stem cells for the regeneration of damaged tissues, Expert Opinion, Cell- & Tissue-based Therapy, Expert Opin. Biol. Ther. (2006) pp. 567-578 Informa UK Ltd.69Planat-B�nard, V., et al., "Spontaneous Cardiomyocyte Differentiation From Adipose Tissue Stroma Cells," Adipose-Derived Cell Cardiomyocyte (2004) pp. 223-229 American Heart Association, Inc.70Plasmax(TM) Plasma Concentrate, brochure (2006) 5 pages Biomet Biologics, Inc.71Plasmax� Plasma Concentrate, brochure (2006) 5 pages Biomet Biologics, Inc.72Rangappa, Sunil, M.D., "Transformation of Adult Mesenchymal Stem Cells Isolated From the Fatty Tissue Into Cardiomyocytes," Adult Stem Cells Transformed into Cardiomyoctyes, (2003) pp. 775-779 Ann Thorac Surg.73Rigotti, M.D., et al, "Clinical Treatment of Radiotherapy Tissue Damage by Lipoaspirate Transplant: A Healing Process Mediated by Adipose-Derived Adult Stem Cells," Plastic and Reconstructive Surgery, Breast, PRS Journal vol. 119, No. 5, Stem Cell Therapy for Angiogenesis, (Pub. 2005) pp. 1409-1422.74Rubin, M.D., et al, "Clinical Treatment of Radiotherapy Tissue Damage by Lipoaspirate Transplant: A Healing Process Mediated by Adipose-Derived Adult Stem Cells," Plastic and Reconstructive Surgery, Discussion vol. 119, No. 5, Stem Cell Therapy for Angiogenesis, (2007) pp. 1423-1424.75Sanal, M. "Does fibrin glue cause foreign body reactions? [letter]." Eur J Pediatr Surg 3 (3 1993): 190 (1 page).76Sanal, M., H. Dogruyol, A. Gurpinar, and O. Yerci. "Does fibrin glue cause foreign body reactions?" Eu r J Pediatr Surg 2 (5 1992): 285-6.77Sch�ffler, Andreas, et al., "Concise Review: Adipose Tissue-Derived Stromal Cells-Basic and Clinical Implications for Novel Cell-Based Therapies," Tissue-Specific Stem Cells, Stem Cells� (2007) pp. 818-827 AlphaMed Press.78Sch�ffler, Andreas, et al., "Concise Review: Adipose Tissue-Derived Stromal Cells�Basic and Clinical Implications for Novel Cell-Based Therapies," Tissue-Specific Stem Cells, Stem Cells� (2007) pp. 818-827 AlphaMed Press.79Sigma-Aldrich� Alkaline Phosphatase (Procedure No. 85), drug fact sheet, (2003) pp. 1-2, Sigma-Aldrich, Inc.80Takahashi, Kazutoshi et al., "Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors," Cell, (2007) pp. 1-12, Elsevier Inc.81The American Journal of Surgery, vol. 168, pp. 120-122, Aug. 1994, Roy L. Tawes, Jr., M.D., et al., "Autologous Fibrin Glue: The Last Step in Operative Hemostatis".82The American Surgeon, vol. 55, pp. 166-168, Mar. 1989, William D. Spotnitz, M.D., et al., "Successful Use of Fibrin Glue During 2 Years of Surgery at a University Medical Center".83Vortech(TM) Concentration System, "Do you want a sticky gel to improve the handling of your bone graft?, Platelet Rich Plasma Concentrate, High Volume in 5 Minutes," Biomet Biologics, Inc., Aug. 2005.84Vortech� Concentration System, "Do you want a sticky gel to improve the handling of your bone graft?, Platelet Rich Plasma Concentrate, High Volume in 5 Minutes," Biomet Biologics, Inc., Aug. 2005.85Vox Sanquinis, vol. 68: 82-89, 02/95, Boomgaard Et. al, Pooled Platelet Concentration Prepred by the . . . .86Weis-Fogh, U. S. "Fibrinogen prepared from small blood samples for autologous use in a tissue adhesive system." Eur Surg Res 20 (5-6 1988): 381-9.87Wiseman, David M., David T. Rovee, and Oscar M. Alverez. "Wound Dressings: Design and Use." In Wound Healing: Biochemical & Clinical Aspects,ed. I. Kelman Cohen, Robert F. Diegelmann, and William J. Lindblad. 562-580. 1st ed., Vol. Philadelphia: W. B. Saunders Company, 1992).88Yoon, Eulsik, M.D., Ph.D., et al., "In Vivo Osteogenic Potential of Human Adipose-Derived Stem Cells/Poly Lactide-Co-Glycolic Acid Constructs for Bone Regneration in a Rat Critical-Sized Calvarial Defect Model," Tissue Engineering, vol. 13, No. 3 (2007) pp. 619-627 Mary Ann Liebert, Inc.89Zhang, Duan-zhen, et al., "Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction," Chinese Medical Journal, vol. 120, No. 4 (2007) pp. 300-307 General Hospital of Shenyang Military Region, Shenyang, China.90Zuk, Patricia A., Ph.D., "Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies," Tissue Engineering, vol. 7, No. 2, (2001) pp. 211-228 Mary Ann Liebert, Inc.Classifications U.S. Classification494/37, 494/63, 494/43, 494/3, 210/740, 494/47International ClassificationB01D21/26Cooperative ClassificationB04B2005/0464, A61M1/3693, B04B5/0442European ClassificationA61M1/36Z, B04B5/04CLegal EventsDateCodeEventDescriptionJan 3, 2012CCCertificate of correctionNov 12, 2009ASAssignmentOwner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FORFree format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC;AND OTHERS;REEL/FRAME:023505/0241Effective date: 20091111Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC AND OTHERS;US-ASSIGNMENT DATABASE UPDATED:20100216;REEL/FRAME:23505/241Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC AND OTHERS;US-ASSIGNMENT DATABASE UPDATED:20100225;REEL/FRAME:23505/241Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC AND OTHERS;US-ASSIGNMENT DATABASE UPDATED:20100304;REEL/FRAME:23505/241Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC AND OTHERS;US-ASSIGNMENT DATABASE UPDATED:20100318;REEL/FRAME:23505/241Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC AND OTHERS;US-ASSIGNMENT DATABASE UPDATED:20100422;REEL/FRAME:23505/241Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC AND OTHERS;US-ASSIGNMENT DATABASE UPDATED:20100429;REEL/FRAME:23505/241Free format text: SECURITY AGREEMENT;ASSIGNORS:LVB ACQUISITION, INC.;BIOMET, INC.;BIOMET 3I, LLC AND OTHERS;REEL/FRAME:23505/241May 23, 2008ASAssignmentOwner name: BIOMET BIOLOGICS, LLC, INDIANAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOEPPNER, JACY C.;REEL/FRAME:020989/0877Effective date: 20080522RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services©2012 Google